|
SCLT1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.99890000005276E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.144370E-03 |
| Normal-vs-Stage2 |
8.40640000054904E-07 |
| Normal-vs-Stage3 |
2.17830000004415E-06 |
| Normal-vs-Stage4 |
2.84110000003945E-06 |
| Stage1-vs-Stage2 |
5.403300E-03 |
| Stage1-vs-Stage3 |
1.440090E-02 |
| Stage1-vs-Stage4 |
9.278700E-03 |
| Stage2-vs-Stage3 |
3.689600E-01 |
| Stage2-vs-Stage4 |
8.558200E-01 |
| Stage3-vs-Stage4 |
4.885800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.97834999999813E-05 |
| Normal-vs-AfricanAmerican |
2.880100E-03 |
| Normal-vs-Asian |
2.286200E-02 |
| Caucasian-vs-AfricanAmerican |
8.078400E-01 |
| Caucasian-vs-Asian |
2.234800E-01 |
| AfricanAmerican-vs-Asian |
3.090800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.553700E-04 |
| Normal-vs-Female |
2.84880000001042E-06 |
| Male-vs-Female |
7.987200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.216400E-03 |
| Normal-vs-Age(41-60Yrs) |
1.07450000008669E-07 |
| Normal-vs-Age(61-80Yrs) |
1.75520000000873E-06 |
| Normal-vs-Age(81-100Yrs) |
2.257200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.537470E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.283800E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.629600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.903800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.634000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.736800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.964400E-02 |
| Classical-VS-Follicular |
4.215500E-02 |
| Classical-VS-Other |
1.711600E-01 |
| Classical-VS-Normal |
4.173400E-04 |
| Tall-VS-Follicular |
7.081200E-01 |
| Tall-VS-Other |
6.934200E-01 |
| Tall-VS-Normal |
5.219500E-04 |
| Follicular-VS-Other |
4.869800E-01 |
| Follicular-VS-Normal |
1.61462999999085E-05 |
| Other-VS-Normal |
8.962900E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.92770000001708E-06 |
| Normal-vs-N1 |
1.161830E-03 |
| N0-vs-N1 |
6.456400E-01 |
|
|
